Skip to main content
PMC home page
Age logoLink to Age
. 2005 May 2;27(1):5–16. doi: 10.1007/s11357-005-4003-x

Lifelong vitamin E intake retards age-associated decline of spatial learning ability in apoE-deficient mice

Shelley R McDonald 1, Michael J Forster 1,2,✉
PMCID: PMC3456095  PMID: 23598599

Abstract

The potential for lifelong vitamin E supplementation to delay age-associated cognitive decline was tested in apoE-deficient and wild-type C57BL/6 mice. Beginning at eight weeks of age, the mice were maintained on a control diet or diets supplemented with dl-α-tocopheryl acetate yielding approximate daily intakes of either 20 or 200 mg/kg body weight. When 6 or 18 months of age, cognitive functioning of the mice was assessed using swim maze and discriminated avoidance testing procedures. For the mice maintained on control diets, the age-related declines in swim maze performance were relatively larger in apoE-deficient mice when compared with wild-type. On the other hand, age-associated declines in learning and working memory for discriminated avoidance were similar in the two genotypes. The 200-mg/kg dose of vitamin E prevented the accelerated decline in spatial learning apparent in 18-month-old apoE-deficient mice, but had no equivalent effect on performance declines attributable to normal aging in the wild-type mice. Vitamin E supplementation failed to prevent age-related impairments in learning and memory for discriminated avoidance observed in both the wild-type and apoE-deficient mice. The current findings are consistent with the hypothesis that apoE deficiency confers an accelerated, though probably selective, loss of brain function with age. This loss of function would appear to involve pathogenic oxidative mechanisms that can be prevented or offset by antioxidant supplementation.

Key words: alpha-Tocopherol, apolipoprotein E, apoE−/− mice, body weight, brain aging, C57BL/6 mice, cognitive decline, learning and memory, oxidative stress, spatial memory, survival, vitamin E, working memory

Full Text

The Full Text of this article is available as a PDF (495.0 KB).

References

  1. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe−/− mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999;19:4867–4880. doi: 10.1523/JNEUROSCI.19-12-04867.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss-Coray T, et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience. 2000;97:207–210. doi: 10.1016/S0306-4522(00)00069-5. [DOI] [PubMed] [Google Scholar]
  3. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, et al. Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med. 2002;33:562–571. doi: 10.1016/S0891-5849(02)00914-0. [DOI] [PubMed] [Google Scholar]
  4. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, et al. Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem. 2002;82:1524–1532. doi: 10.1046/j.1471-4159.2002.01103.x. [DOI] [PubMed] [Google Scholar]
  5. Choi J, Forster MJ, McDonald SR, Weintraub ST, Carroll CA, Gracy RW. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer’s disease. Free Radic Biol Med. 2004;36:1155–1162. doi: 10.1016/j.freeradbiomed.2004.02.002. [DOI] [PubMed] [Google Scholar]
  6. Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, et al. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging. 2002;23:777–785. doi: 10.1016/S0197-4580(02)00016-7. [DOI] [PubMed] [Google Scholar]
  7. Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, et al. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol. 2004;147:62–67. doi: 10.1016/j.jneuroim.2003.10.015. [DOI] [PubMed] [Google Scholar]
  8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  9. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  10. Fisher A, Brandeis R, Chapman S, Pittel Z, Michaelson DM. M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. J Neurochem. 1998;70:1991–1997. doi: 10.1046/j.1471-4159.1998.70051991.x. [DOI] [PubMed] [Google Scholar]
  11. Forster MJ, Lal H. Within-subject behavioral analysis of recent memory in aging mice. Behav Pharmacol. 1992;3:337–349. [PubMed] [Google Scholar]
  12. Forster MJ, Prather PL, Patel SR, Lal H. The benzodiazepine receptor inverse agonist RO 15-3505 reverses recent memory deficits in aged mice. Pharmacol Biochem Behav. 1995;51:557–560. doi: 10.1016/0091-3057(95)00063-3. [DOI] [PubMed] [Google Scholar]
  13. Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci USA. 1996;93:4765–4769. doi: 10.1073/pnas.93.10.4765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett. 1995;199:1–4. doi: 10.1016/0304-3940(95)12006-p. [DOI] [PubMed] [Google Scholar]
  15. Gordon I, Genis I, Grauer E, Sehayek E, Michaelson DM. Biochemical and cognitive studies of apolipoprotein-E-deficient mice. Mol Chem Neuropathol. 1996;28:97–103. doi: 10.1007/BF02815210. [DOI] [PubMed] [Google Scholar]
  16. Gozes I. Apolipoprotein E knockout mice as a model of behavioral dysfunction. J Mol Neurosci. 2004;23:149–150. doi: 10.1385/JMN:23:3:149. [DOI] [PubMed] [Google Scholar]
  17. Grootendorst J, Kloet ER, Dalm S, Oitzl MS. Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience. Neuroscience. 2001;108:237–247. doi: 10.1016/s0306-4522(01)00412-2. [DOI] [PubMed] [Google Scholar]
  18. Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer’s disease. J Mol Neurosci. 2004;23:189–204. doi: 10.1385/JMN:23:3:189. [DOI] [PubMed] [Google Scholar]
  19. Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996;40:55–66. doi: 10.1002/ana.410400111. [DOI] [PubMed] [Google Scholar]
  20. Joseph JA, Shukitt-Hale B, Denisova NA, Prior RL, Cao G, Martin A, et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci. 1998;18:8047–8055. doi: 10.1523/JNEUROSCI.18-19-08047.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lass A, Forster MJ, Sohal RS. Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radic Biol Med. 1999;26:1375–1382. doi: 10.1016/s0891-5849(98)00330-x. [DOI] [PubMed] [Google Scholar]
  22. Lee Y, Aono M, Laskowitz D, Warner DS, Pearlstein RD. Apolipoprotein E protects against oxidative stress in mixed neuronal–glial cell cultures by reducing glutamate toxicity. Neurochem Int. 2004;44:107–118. doi: 10.1016/s0197-0186(03)00112-8. [DOI] [PubMed] [Google Scholar]
  23. Lomnitski L, Chapman S, Hochman A, Kohen R, Shohami E, Chen Y, et al. Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. Biochim Biophys Acta. 1999;1453:359–368. doi: 10.1016/s0925-4439(99)00010-1. [DOI] [PubMed] [Google Scholar]
  24. Mahley RW, Rall SC., Jr Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–537. doi: 10.1146/annurev.genom.1.1.507. [DOI] [PubMed] [Google Scholar]
  25. Martin A, Janigian D, Shukitt-Hale B, Prior RL, Joseph JA. Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain Res. 1999;845:50–59. doi: 10.1016/s0006-8993(99)01923-x. [DOI] [PubMed] [Google Scholar]
  26. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol. 1995;136:107–122. doi: 10.1006/exnr.1995.1088. [DOI] [PubMed] [Google Scholar]
  27. Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 1997;751:307–314. doi: 10.1016/s0006-8993(96)01420-5. [DOI] [PubMed] [Google Scholar]
  28. Matthews RT, Beal MF. Increased 3-nitrotyrosine in brains of Apo E-deficient mice. Brain Res. 1996;718:181–184. doi: 10.1016/0006-8993(95)01576-0. [DOI] [PubMed] [Google Scholar]
  29. McDonald SR, Lal H, Forster MJ. Accelerated cognitive decline in apolipoprotein E deficient aging mice is independent of sensorimotor decline. Soc Neurosci Abstr. 1997;23:2005. [Google Scholar]
  30. McDonald SR, Sohal RS, Forster MJ. Concurrent administration of coenzyme Q10 and α-tocopherol improves learning in aged mice. Free Radic Biol Med. 2005;38:729–736. doi: 10.1016/j.freeradbiomed.2004.11.014. [DOI] [PubMed] [Google Scholar]
  31. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14:55–61. doi: 10.1038/ng0996-55. [DOI] [PubMed] [Google Scholar]
  32. Montine TJ, Montine KS, Graham OS, Roberts DG, Morrow LJ, et al. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6 mice. Exp Neurol. 1999;158:234–241. doi: 10.1006/exnr.1999.7067. [DOI] [PubMed] [Google Scholar]
  33. Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K, et al. Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience. 2001;107:415–431. doi: 10.1016/S0306-4522(01)00374-8. [DOI] [PubMed] [Google Scholar]
  34. Oitzl MS, Mulder M, Lucassen PJ, Havekes LM, Grootendorst J, Kloet ER. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 1997;752:189–196. doi: 10.1016/S0006-8993(96)01448-5. [DOI] [PubMed] [Google Scholar]
  35. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA. 1992;89:4471–4475. doi: 10.1073/pnas.89.10.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pratico D, Tangirala RK, Rader DJ, Rokach J, Fitzgerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat Med. 1998;4:1189–1192. doi: 10.1038/2685. [DOI] [PubMed] [Google Scholar]
  37. Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, Pitas RE, et al. Apolipoprotein E and cognitive performance. Nature. 2000;404:352–354. doi: 10.1038/35006165. [DOI] [PubMed] [Google Scholar]
  38. Ramassamy C, Krzywkowski P, Averill D, Lussier-Cacan S, Theroux L, Christen Y, et al. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Brain Res Mol Brain Res. 2001;86:76–83. doi: 10.1016/S0169-328X(00)00268-0. [DOI] [PubMed] [Google Scholar]
  39. Reed T, Carmelli D, Swan GE, Breitner JC, Welsh KA, Jarvik GP, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol. 1994;51:1189–1192. doi: 10.1001/archneur.1994.00540240033012. [DOI] [PubMed] [Google Scholar]
  40. Reich EE, Montine KS, Gross MD, Roberts LJ, II, Swift LL, Morrow JD, et al. Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice. J Neurosci. 2001;21:5993–5999. doi: 10.1523/JNEUROSCI.21-16-05993.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu Rev Med. 1996;47:387–400. doi: 10.1146/annurev.med.47.1.387. [DOI] [PubMed] [Google Scholar]
  42. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43:1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  43. Shea TB, Rogers E, Ashline D, Ortiz D, Sheu MS. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med. 2002;33:1115–1120. doi: 10.1016/S0891-5849(02)01001-8. [DOI] [PubMed] [Google Scholar]
  44. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sumien N, Forster MJ, Sohal RS. Supplementation with vitamin E fails to attenuate oxidative damage in aged mice. Exp Gerontol. 2003;38:699–704. doi: 10.1016/S0531-5565(03)00068-8. [DOI] [PubMed] [Google Scholar]
  46. Sumien N, Heinrich KR, Sohal RS, Forster MJ. Short-term vitamin E intake fails to improve cognitive or psychomotor performance of aged mice. Free Radic Biol Med. 2004;36:1424–1433. doi: 10.1016/j.freeradbiomed.2004.02.081. [DOI] [PubMed] [Google Scholar]
  47. Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice. Neurosci Lett. 1999;265:218–222. doi: 10.1016/S0304-3940(99)00243-8. [DOI] [PubMed] [Google Scholar]
  48. Veinbergs I, Mallory M, Sagara Y, Masliah E. Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur J Neurosci. 2000;12:4541–4546. doi: 10.1046/j.1460-9568.2000.01308.x. [DOI] [PubMed] [Google Scholar]
  49. Veurink G, Liu D, Taddei K, Perry G, Smith MA, Robertson TA, et al. Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radic Biol Med. 2003;34:1070–1077. doi: 10.1016/S0891-5849(03)00042-X. [DOI] [PubMed] [Google Scholar]
  50. Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene–environment interaction. Neurology. 2000;54:1949–1954. doi: 10.1212/wnl.54.10.1949. [DOI] [PubMed] [Google Scholar]

Articles from Age are provided here courtesy of American Aging Association

RESOURCES